A Phase I/IIa Sporozoite Challenge Study to Assess the Safety and Protective Efficacy of Adjuvanted R21 at Two Different Doses and the Combination Malaria Vaccine Candidate Regimen of Adjuvanted R21 + ChAd63 and MVA Encoding ME-TRAP
Phase of Trial: Phase I/II
Latest Information Update: 08 Aug 2017
At a glance
- Drugs ME-TRAP malaria DNA vaccine Okairos (Primary) ; R 21 (Primary) ; Adjuvants; Antihistamines; Artemether/lumefantrine; Cyclizine; Paracetamol
- Indications Malaria
- Focus Adverse reactions; Therapeutic Use
- 03 Jul 2017 Planned End Date changed from 1 Jan 2018 to 1 Aug 2018.
- 03 Jul 2017 Planned primary completion date changed from 1 Jan 2018 to 1 Aug 2018.
- 02 Jan 2017 New trial record